March 20, 2024 Product Data: Active GLP-1 (7-36) amide Chemiluminescence ELISA ALPCOs Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples
The FDA stated in January 2024 that their preliminary evaluation does not find that GLP-1 medicines cause suicidal thoughts or actions, though they continue monitoring and cannot definitively rule out a small risk
Investments are significant in the region, driving rapid product launches, clinical trials for new indications, and early adoption of innovative GLP-1 formulations, including oral and long-acting injectables
The standards exist, but they are applied through the pharmacy contractor, Express Scripts, during the review process rather than explained step-by-step in official guidance
these should be the preferred recommendation for obese women with PCOS